INSULET CORP·4

Mar 14, 5:07 PM ET

Abdel-Malek Aiman 4

4 · INSULET CORP · Filed Mar 14, 2019

Insider Transaction Report

Form 4
Period: 2019-03-12
Abdel-Malek Aiman
SVP, Advanced Technology
Transactions
  • Exercise/Conversion

    Common Stock

    2019-03-12$31.20/sh+19,915$621,34843,907 total
  • Exercise/Conversion

    Common Stock

    2019-03-12$46.22/sh+5,686$262,80749,593 total
  • Exercise/Conversion

    Common Stock

    2019-03-12$74.50/sh+1,748$130,22651,341 total
  • Sale

    Common Stock

    2019-03-12$94.03/sh27,349$2,571,61323,992 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2019-03-1219,91511,967 total
    Exercise: $31.20Exp: 2026-03-28Common Stock (19,915 underlying)
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2019-03-125,6865,686 total
    Exercise: $46.22Exp: 2027-02-22Common Stock (5,686 underlying)
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2019-03-121,7485,247 total
    Exercise: $74.50Exp: 2028-02-14Common Stock (1,748 underlying)
Footnotes (3)
  • [F1]Includes 4,674 restricted stock units granted on March 28, 2016, which vest on March 28, 2019; 4,006 performance share units granted on March 28, 2016, which vest on March 28, 2019; 1,443 restricted stock units granted on February 22, 2017, which vest on February 22, 2020; and 1,790 restricted stock units granted on February 14, 2018, which vest one-half of the total units on February 14, 2020 and one-half of the total units on February 14, 2021, subject to continued employment. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date.
  • [F2]The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $93.67 to $94.53. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
  • [F3]This option is subject to a four-year vesting period with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT